OBJECTIVE: To determine how neuroanatomic variation in children and adolescents with fragile X syndrome is linked to reduced levels of the fragile X mental retardation-1 protein and to aberrant cognition and behavior. METHODS: This study included 84 children and adolescents with the fragile X full mutation and 72 typically developing control subjects matched for age and sex. Brain morphology was assessed with volumetric, voxel-based, and surface-based modeling approaches. Intelligence quotient was evaluated with standard cognitive testing, whereas abnormal behaviors were measured with the Autism Behavior Checklist and the Aberrant Behavior Checklist. RESULTS: Significantly increased size of the caudate nucleus and decreased size of the posterior cerebellar vermis, amygdala, and superior temporal gyrus were present in the fragile X group. Subjects with fragile X also demonstrated an abnormal profile of cortical lobe volumes. A receiver operating characteristic analysis identified the combination of a large caudate with small posterior cerebellar vermis, amygdala, and superior temporal gyrus as distinguishing children with fragile X from control subjects with a high level of sensitivity and specificity. Large caudate and small posterior cerebellar vermis were associated with lower fragile X mental retardation protein levels and more pronounced cognitive deficits and aberrant behaviors. INTERPRETATION: Abnormal development of specific brain regions characterizes a neuroanatomic phenotype associated with fragile X syndrome and may mediate the effects of FMR1 gene mutations on the cognitive and behavioral features of the disorder. Fragile X syndrome provides a model for elucidating critical linkages among gene, brain, and cognition in children with serious neurodevelopmental disorders.
OBJECTIVE: To determine how neuroanatomic variation in children and adolescents with fragile X syndrome is linked to reduced levels of the fragile X mental retardation-1 protein and to aberrant cognition and behavior. METHODS: This study included 84 children and adolescents with the fragile X full mutation and 72 typically developing control subjects matched for age and sex. Brain morphology was assessed with volumetric, voxel-based, and surface-based modeling approaches. Intelligence quotient was evaluated with standard cognitive testing, whereas abnormal behaviors were measured with the Autism Behavior Checklist and the Aberrant Behavior Checklist. RESULTS: Significantly increased size of the caudate nucleus and decreased size of the posterior cerebellar vermis, amygdala, and superior temporal gyrus were present in the fragile X group. Subjects with fragile X also demonstrated an abnormal profile of cortical lobe volumes. A receiver operating characteristic analysis identified the combination of a large caudate with small posterior cerebellar vermis, amygdala, and superior temporal gyrus as distinguishing children with fragile X from control subjects with a high level of sensitivity and specificity. Large caudate and small posterior cerebellar vermis were associated with lower fragile X mental retardation protein levels and more pronounced cognitive deficits and aberrant behaviors. INTERPRETATION: Abnormal development of specific brain regions characterizes a neuroanatomic phenotype associated with fragile X syndrome and may mediate the effects of FMR1 gene mutations on the cognitive and behavioral features of the disorder. Fragile X syndrome provides a model for elucidating critical linkages among gene, brain, and cognition in children with serious neurodevelopmental disorders.
Authors: I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel Journal: Science Date: 1991-05-24 Impact factor: 47.728
Authors: Eric Hollander; Evdokia Anagnostou; William Chaplin; Katherine Esposito; M Mehmet Haznedar; Elizabeth Licalzi; Stacey Wasserman; Latha Soorya; Monte Buchsbaum Journal: Biol Psychiatry Date: 2005-08-01 Impact factor: 13.382
Authors: Jennifer G Levitt; Joseph O'Neill; Rebecca E Blanton; Susan Smalley; David Fadale; James T McCracken; Donald Guthrie; Arthur W Toga; Jeffrey R Alger Journal: Biol Psychiatry Date: 2003-12-15 Impact factor: 13.382
Authors: S K Madsen; A J Ho; X Hua; P S Saharan; A W Toga; C R Jack; M W Weiner; P M Thompson Journal: Neurobiol Aging Date: 2010-06-11 Impact factor: 4.673
Authors: Scott S Hall; Amy A Lightbody; Melissa Hirt; Ava Rezvani; Allan L Reiss Journal: J Am Acad Child Adolesc Psychiatry Date: 2010-08-01 Impact factor: 8.829
Authors: Yi-Yu Chou; Natasha Leporé; Ming-Chang Chiang; Christina Avedissian; Marina Barysheva; Katie L McMahon; Greig I de Zubicaray; Matthew Meredith; Margaret J Wright; Arthur W Toga; Paul M Thompson Journal: Neuroimage Date: 2008-11-07 Impact factor: 6.556